Carterra® Inc., will host a series of symposia entitled, "The therapeutic antibody revolution in the post-genomics era". Presentations will demonstrate how high throughput surface plasmon resonance using the Carterra LSA™ is facilitating a paradigm shift in antibody screening.

Northern Antibiotics is working on a new antibiotic molecule, a derivative of polymyxin, that has the potential to become one of the few last-resort weapons against bacteria resistant to all antibiotics now in use.

Linkam Scientific Instruments has made a series of investments under the leadership of new Managing Director, Ross Browne.

Owlstone Medical has announced advancements in their Breath Biopsy Platform. These are designed to support biomarker discovery programs and to measure levels of known volatile organic compounds (VOCs) on breath.

Gyros Protein Technologies AB, has introduced PurePep™ Chorus, its next-generation automated peptide synthesis platform.

Rentschler Biopharma SE has announced its line-up of activities during the BioProcess International Conference, focusing on its new facility and the projects taking place there.

Batavia Biosciences has announced an agreement to utilize Horizon Discovery’s GS knockout CHO K1 cell line expression system for the development of high yield anti-Zika virus antibody-expressing cell lines.

BioCity has announced investment in Maxwellia’s prescription (Rx) to Over the Counter (OTC) switch incubator. The creation of new OTC products potentially enables quicker therapeutic outcomes for many.

Calendar-based plug-in for Green Button Go Automation Scheduling Software eliminates bottlenecks on high-value lab equipment.

Samplix announced the commercial launch of its Xdrop™ sample preparation products for PCR-free target enrichment yet maintaining PCR-level specificity.